- EDO-S101 PHARMACEUTICAL COMBINATION COMPRISING A CLASS III RECEPTOR TYROSINE KINASE INHIBITOR AND THE ALKYLATING HISTONE-DEACETYLASE INHIBITOR FUSION MOLECULE EDO-S101 TOGETHER WITH ITS USE IN THE TREATMENT OF CANCER

摘要

The invention relates to a combination comprising a class III receptor tyrosine kinase inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof; A pharmaceutical composition and kit comprising said combination; A combination, composition or kit for use in the treatment of cancer; The method comprising administering to a patient in need thereof an effective amount of the combination, composition or kit.